ArticlePublic health challenges2026
The Global Impact of Bacterial Antimicrobial Resistance: Addressing Gaps and Future Strategies.
Article in Public health challenges, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Combating multidrug-resistant pathogens, breast cancer (MCF-7) and hepatocellular carcinoma (HepG2) using biofabricated zinc oxide nanoparticles.Scientific reports · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) has become one of the most pressing threats to public health worldwide. According to the Global Burden of Disease 2021 report, AMR was linked to 4.71 million deaths, of which 1.14 million were directly caused by bacterial resistance. The impact is not felt equally, with low- and middle-income countries (LMICs) carrying the greatest burden due to weak health systems, limited diagnostics and widespread misuse of antibiotics in both healthcare and agriculture. Self-medication and poor regulatory oversight further accelerate the crisis. This article explores these challenges and stresses the urgent need for a coordinated 'One Health' approach that connects human, animal and environmental health. Strengthening surveillance, investing in new antibiotics and promoting responsible use through stewardship programs and community awareness are critical steps forward. Without decisive global action, AMR could claim over 8 million lives each year by 2050; yet, with timely interventions, especially in LMICs, up to 92 million deaths could be prevented, protecting future generations from its devastating consequences.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.